ArticleJournal of neurology2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
Aurora Zanghì et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it